Patents by Inventor Enoch Bortey

Enoch Bortey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11779571
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: October 10, 2023
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: William Forbes, Enoch Bortey
  • Patent number: 11564912
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: January 31, 2023
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: William P. Forbes, Enoch Bortey
  • Publication number: 20230000841
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: August 22, 2022
    Publication date: January 5, 2023
    Inventors: William P. Forbes, Enoch Bortey
  • Publication number: 20220031675
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: March 10, 2021
    Publication date: February 3, 2022
    Inventors: William Forbes, Enoch Bortey
  • Patent number: 10765667
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: September 8, 2020
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: William Forbes, Enoch Bortey
  • Publication number: 20200276170
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Application
    Filed: April 14, 2020
    Publication date: September 3, 2020
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • Publication number: 20200230116
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 23, 2020
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • Publication number: 20200206199
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: January 9, 2020
    Publication date: July 2, 2020
    Inventors: William Forbes, Enoch Bortey
  • Publication number: 20200121653
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: September 19, 2019
    Publication date: April 23, 2020
    Inventors: William Forbes, Enoch Bortey
  • Patent number: 10610522
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: April 7, 2020
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • Publication number: 20200061032
    Abstract: The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The invention further provides methods for treating these subjects.
    Type: Application
    Filed: April 23, 2019
    Publication date: February 27, 2020
    Inventors: William Forbes, Kunal Merchant, Enoch Bortey, Audrey Shaw
  • Patent number: 10493064
    Abstract: The instant application provides methods of diagnosing and treating a subject having IBS. In certain embodiments, the methods also include diagnosing subjects who will respond to IBS treatment with rifaximin.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: December 3, 2019
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Anthony Fodor, Enoch Bortey, William Forbes
  • Patent number: 10456384
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: October 29, 2019
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: William Forbes, Enoch Bortey
  • Publication number: 20190231771
    Abstract: Presented herein are methods for treatment or prevention of opioid induced constipation by administration of oral compositions of methylnaltrexone. The methods are based, at least in part, on the identification of subjects that are particularly susceptible to such treatment and optimal dosages of such oral compositions to treat or prevent opioid induced constipation and, further, to minimize the occurrence of adverse events associated with such treatment.
    Type: Application
    Filed: November 30, 2018
    Publication date: August 1, 2019
    Applicant: Salix Pharmaceuticals, Ltd.
    Inventor: Enoch Bortey
  • Patent number: 10314828
    Abstract: The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The invention further provides methods for treating these subjects.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: June 11, 2019
    Assignee: Salix Pharmaceuticals, Ltd
    Inventors: William Forbes, Kunal Merchant, Enoch Bortey, Audrey Shaw
  • Publication number: 20180271842
    Abstract: The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The invention further provides methods for treating these subjects.
    Type: Application
    Filed: November 28, 2017
    Publication date: September 27, 2018
    Inventors: William Forbes, Kunal Merchant, Enoch Bortey, Audrey Shaw
  • Publication number: 20180243272
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: February 22, 2018
    Publication date: August 30, 2018
    Inventors: William Forbes, Enoch Bortey
  • Patent number: 9931325
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: April 3, 2018
    Assignee: Salix Pharmaceuticals, Ltd.
    Inventors: William Forbes, Enoch Bortey
  • Patent number: 9855254
    Abstract: The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The invention further provides methods for treating these subjects.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: January 2, 2018
    Assignee: Salix Pharmaceuticals, Ltd.
    Inventors: William Forbes, Kunal Merchant, Enoch Bortey, Audrey Shaw
  • Publication number: 20170182013
    Abstract: The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
    Type: Application
    Filed: January 4, 2017
    Publication date: June 29, 2017
    Inventors: William Forbes, Enoch Bortey